Breztri (budesonide/glycopyrrolate/formoterol fumarate), meanwhile, has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD).Sales of Breztri were $677 million last year, a rise of 73%, although AZ does not yet break out Airsupra revenues individually, as it is still in the rollout phase.
https://pharmaphorum.com/news/smart-sensor-cleared-use-az-asthma-copd-inhalers
Breztri (budesonide/glycopyrrolate/formoterol fumarate),...
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.021M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1169164 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 271020 | 1 |
View Market Depth
| Last trade - 10.33am 21/05/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable